期刊文献+

^(18)F-FES PET/CT联合^(18)F-FDG PET/CT luminal A型乳腺癌显像1例

Luminal type A breast cancer imaging by 18 F-FES PET/CT and 18 F-FDG PET/CT:one case report
下载PDF
导出
摘要 患者女,59岁。检查发现左乳腺肿块2周。患者2周前自扪及左乳腺包块,活动度可,触之略痛,乳头无异常分泌物,周围皮肤无红肿。查体提示左乳腺外上象限可扪及一结节灶,大小约1.5 cm×2.0 cm,质韧,活动度可,有压痛,左腋下淋巴结未触及肿大。
出处 《医学影像学杂志》 2023年第4期739-740,共2页 Journal of Medical Imaging
  • 相关文献

参考文献4

二级参考文献45

  • 1侯意枫,袁胜涛,李鹤成,吴炅,陆劲松,陆丽娟,刘刚,沈镇宙,丁健,邵志敏.雌激素受体β亚型对人乳腺癌细胞株生物学特性的影响[J].中华肿瘤杂志,2005,27(7):389-392. 被引量:10
  • 2Hospers GA, Helmond FA, de Vries EG, et al. PET imaging of steroid receptor expression in breast and prostate cancer. Curr Pharm Des, 2008, 14(28): 3020-3032.
  • 3Kumar P, Mercer J, Doerkson C, et al. Clinical production, stability studies and PET imaging with 16-alpha-[18F]-fluoroestradiol ([18F]-FES) in ER positive breast cancer patients. J Pharm Pharm Sci, 2007, 10(2): 256s-265s.
  • 4Mortimer JE, Dehdashti F, Siegel BA, et al. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16a-[18F]-173-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res, 1996, 2(6): 933- 939.
  • 5Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med, 2005, 35(2): 84-99.
  • 6Linden HM, Stekhova SA, Link JM, et al. Quantitative fluoroestra-diol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol, 2006, 24(18): 2793-2799.
  • 7Linden HM, Kurland BF, Peterson LM, et al. Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer. Clin Cancer Res, 2011,17(14): 4799-4805.
  • 8van Kruchten M, Glaudemans AW, de Vries EF, et al. PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma. J Nucl Med, 2012, 53(2): 182-190.
  • 9Tsujikawa T, Yoshida Y, Kudo T, et al. Functional images reflect aggressiveness of endometrial carcinoma : estrogen receptor expression combined with 18F-FDG PET. J Nucl Med, 2009, 50(10): 1598-1604.
  • 10ROSE C,THORPE S M,ANDERSEN K W. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high estrogen receptor values[J].{H}LANCET,1985,(8419):16-19.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部